Chargement en cours...
ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia in Jordan
Mutations of the BCR-ABL tyrosine kinase domain constitute a major cause of resistance to tyrosine kinase inhibitors in patients with chronic myelogenous leukemia (CML). In this study, we analyzed peripheral blood samples from 185 Jordanian CML patients for ABL mutations, who were on imatinib for a...
Enregistré dans:
| Auteurs principaux: | , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc.
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3483047/ https://ncbi.nlm.nih.gov/pubmed/23009571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/gtmb.2012.0147 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|